Cite
Does comorbid obesity or chronic pancreatitis influence the choice and effectiveness of glucose-lowering therapy in type 2 diabetic patients?
MLA
Uliana Hevko, et al. “Does Comorbid Obesity or Chronic Pancreatitis Influence the Choice and Effectiveness of Glucose-Lowering Therapy in Type 2 Diabetic Patients?” Archives of the Balkan Medical Union, vol. 56, Mar. 2021, pp. 24–32. EBSCOhost, https://doi.org/10.31688/abmu.2021.56.1.03.
APA
Uliana Hevko, Yulia Danylevych, Lyudmyla Mazur, Svitlana Danchak, Mariya Marushchak, & Inna Krynytska. (2021). Does comorbid obesity or chronic pancreatitis influence the choice and effectiveness of glucose-lowering therapy in type 2 diabetic patients? Archives of the Balkan Medical Union, 56, 24–32. https://doi.org/10.31688/abmu.2021.56.1.03
Chicago
Uliana Hevko, Yulia Danylevych, Lyudmyla Mazur, Svitlana Danchak, Mariya Marushchak, and Inna Krynytska. 2021. “Does Comorbid Obesity or Chronic Pancreatitis Influence the Choice and Effectiveness of Glucose-Lowering Therapy in Type 2 Diabetic Patients?” Archives of the Balkan Medical Union 56 (March): 24–32. doi:10.31688/abmu.2021.56.1.03.